Pervichnyy giperal'dosteronizm. Klinicheskie rekomendatsii

Cover Page

Abstract


Расширенный реферат по материалам J Clin Endocrin Metab. June 13. 2008

D G Bel'tsevich

  1. Atkins D, Best D, Briss PA. Eccles M. Falck-Yiter Y, Flottorp S, Guyall GH. Harbour RT, Haugh MC. Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N. Mason J. Middleton P, Mrukowiez J. O'Connell D, Oxman AD, i’hiliips B, Schunemann HJ. EdejerTT, Varonen H, Vist GE, Williams JW, Jr., Zaza S 2004 Grading quality of evidence and strength of recommendations. BMJ 328:1490
  2. Swiglo BA, Murad M11, Schunemann HJ, Kunz R, Vigersky RA. Guyatt GH, Moutori VM 2008 A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab 93:666-73
  3. Andersen GS, Toftdahl DB, Lund JO, Strandgaard S, Nielsen PF. 1988 The incidence rate of phaeochromocytoma and Conn's syndrome in Denmark, 1977-1981. J Hum H ypertens 2:187-9
  4. Berglund G, Andersson O, Wilhelmsen L 1976 Prevalence of primary and secondary hypertension: studies in a random population sample. Br Med J 2:554-6
  5. Fishman LM. Kuchcl O, Liddle GW. Michelakis AM. Gordon RD. Chick WT 1968 Incidence ofprimary aldosteronism uncomplicated "essential" hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria. JAMA 205:497502
  6. Kaplan NM 1967 Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism. Ann Intern Med 66:1079-90
  7. Streeten DH, Tomycz N, Anderson GH 1979 Reliability of screening methods for the diagnosis of primary aldosteronism. Am J Med 67:403-13
  8. Tucker RM, Labarthe DR 1977 Frequency of surgical treatment for hypertension in adults at the Mayo Clinic from 1973 through 1975. Mayo Clin Proc 52:549-5
  9. Sinclair AM, Isles CG, Brown I, Cameron H, Murray GD. Robertson JW 1987 Secondary hypertension in a blood pressure clinic. Arch Intern Med 147:1289-93
  10. Fardclla CE, Mosso L, Gomez-Satichez C, Cortes P. Soto J, Gomez L, Pinto M, Huete A. Ocstrcicher E, Foradori A, Montero.1 2000 Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 85:1863-7
  11. Gordon RD, Slowasser M, Tunny TJ, Klemm SA, Rutherford JC 1994 High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21:315-8
  12. Grim CE, Weinberger MH, Higgins JT. Kramer NJ 1977 Diagnosis of secondary forms of hypertension, A comprehensive protocol. JAMA 237:1331-5
  13. Hamlet SM, Tunny TJ, Woodland E, Gordon RD 1985 Is aldosterone/renin ratio useful to screen a hypertensive population for primary aldosteronism?Clin Exp Pharmacol Physiol 12:249-52
  14. Lim PO, Dow E, Brennan G, Jung RT, MacDonald 'ГМ 2000 High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum 1-Iypertens 14:311 -5
  15. Loh КС. Koay ES, Khaw MC, Emmanuel SC, Young WF, Jr. 2000 Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 85:2854-9
  16. Mosso L. Carvajal C. Gonzalez A, Barraza A, Avila F, Montero J, Huete A, Gederlini A, Fardella CE 2003 Primary aldosteronism and hypertensive disease. Hypertension 42:161 -5
  17. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello M.I, Moretti A. Palumbo G, Parenti G, Porteri E. Semplicini A. Rizzoni D, Rossi E, Boscaro M. Pessina AC, Mantero F 2006 A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48:2293-300
  18. Schwartz GL, Turner ST 2005 Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. ClinChem 51:386-94
  19. Mulatero P, Stowasser M, Loh КС, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF, Jr. 2004 Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89:1045-50
  20. Rossi GP, Bernini G. Desideri G, Fabris B. Ferri C, Giacchetti G, Letizia C, Maccario M, Mannelli M. Matterello MJ. Montemurro D, Palumbo G, Rizzoni D, Rossi E. Pessina AC, Mantero F 2006 Renal damage in primary aldosteronism: results ofthe PAPY Study. Hypertension48:232-8
  21. Millicz P. Girerd X. Plouin PF, Blacher J, Safar ME, Mourad JJ 2005 Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45:1243-8
  22. Stowasser M, Shatman J, Leano R, Gordon RD, Ward G, Cowley D, Marwick TH 2005 Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab 90:5070-6
  23. Rossi E, Regolisti G, Negro A, Sani C, Davoli S, Perazzoli F2002 High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens 15:896-902
  24. Strauch B, Zelinka T, Hampf M, Bernhardt R. Widimsky J, Jr. 2003 Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region. J Hum Hypertens 17:349-52
  25. Williams JS. Williams GH, Raji A. Jeunemaitre X, Brown NJ. Hopkins PN, C'onlin PR 2006 Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum I lypertens 20:129-36
  26. Benchetrit S, Bemhcim J, Podjarny E 2002 Normokalemic hyperaldosteronism in patients with resistant hypertension. ]sr Med Assoc.1 4:17-20
  27. Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Wcissmann P 2002 Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40:892-6
  28. Eide IK.Torjesen PA, Drolsum A,BabovicA, Lillcdahl NP2004 Low-renin status in therapy-resistant hypertension: a clue to efficient treatment. J Hypertens 22:2217-26
  29. Gallay B.I. Ahmad S, Xu L, Toivola B, Davidson RC 2001 Screening for primary aldosteronism without discontinuing hypertensive medications: plasmaaldosterone-renin ratio. Am J Kidney Dis 37:699-705
  30. Goodfriend TL, Calhoun DA 2004 Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension 43:518-24
  31. Calhoun DA, Nishizaka MK, Zaman MA, Harding SM 2004 Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 125:112-7
  32. Aso Y, Homma Y 1992 A survey on incidental adrenal tumors in Japan. J Urol 147:1478-81
  33. Barzon L, Sonino N, Fallo F. Palu G. Boscaro M 2003 Prevalence and natural history of adrenal incidentalomas. EurJ Endocrinol 149:273-85
  34. Bulow B, Ahren В 2002 Adrenal incidentaloma—experience of a standardized diagnostic programme in the Swedish prospective study. J Intern Med 252:239-46
  35. Caplan RH, Strutt PJ. Wickus GG 1994 Subclinical hormone secretion by incidentallydiscoveredadrenal masses. Arch Surg 129:291 -6
  36. Kim HY. Kim SG, Lee KW, Seo JA. Kim NH, Choi KM, Baik SH, Choi DS 2005 Clinical study of adrenal incidentaloma in Korea. Korean J Intern Med 20:303-9
  37. Mantero F, Terzolo M. Amaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opochcr G, Angeli A 2000 A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85:637-44
  38. Rossi GP, Sacchetto A, Viscntin P, Canali C, Graniero GR, Palatini P, Pessina AC 1996 Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 27:1039-45
  39. Montori VM, Young WF, Jr. 2002 Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin North Am 31:619-32, xi
  40. Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H. Izumiyama T 1981 A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med 141:1589-93
  41. McKenna TJ, Sequeira SJ, Heffeman A, Chambers J, Cunningham S 1991 Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab 73:952-7
  42. Stowasser M, Gordon RD, Gunasekera TG, Cowley DC, Ward G, Archibald C, Smithers BM 2003 High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. J Hypertens 21:2149-57
  43. Gordon RD 1995 Primary aldosteronism. J Endocrinol Invest 18:495511

Views

Abstract - 571

PDF (Russian) - 20711

Cited-By


Dimensions


Copyright (c) 2008 .

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies